伊宁哪个医院宫颈息肉治的好伊宁上环还会怀孕吗,伊宁怀孕57天左右不想要孩子怎么办,伊宁妇科检查费用多少,伊宁市博爱医院妇科电话,伊宁中医治男性阳痿早泄,在伊宁取环多少钱,伊宁节育环的种类和价格

BEIJING, Nov. 24 (Xinhua) -- In response to public suspicion stoked by recent dumpling contamination scandals, China's Ministry of Health on Thursday said the new food safety standard for flash-frozen dumplings did not show signs of leniency.The Ministry introduced the new food safety standard on flash-frozen dough or rice products on Thursday.The Ministry has been accused of loosening scrutiny over a disease-generating bacteria in such foods, staphylococcus aureus, or golden staph, which can cause various diseases, including pneumonia and sepsis, and is sometimes life-threatening.The controversy became particularly relevant after several major brands of frozen dumplings have been successively recalled in recent months.In October, a Henan-based company, Zhengzhou Sinian Food Co., Ltd, confirmed the contamination of golden staph in its flash-frozen seafood- and pork-stuffed dumplings.Frozen dumplings made by Hong Kong-based manufacturer Wanchai Ferry were found to contain golden staph in November, and some of its products have been pulled from shelves.The previous standard provided that no golden staph should be tested in such food, while the new one gives a quantitative restriction that the volume of the bacteria should be no more than ten to the fourth degree.Liu Xiumei, a food safety expert with the Chinese Center for Disease Control and Prevention, said at the press conference held by the health ministry that such bacteria becomes inactivate after the food is boiled for a few seconds, and it takes a volume of ten to the fifth degree to generate toxicity.The previous standard could only serve as a general provision due to the lack of quantitative microbiological testing back when it was introduced, Liu said, stressing that the new standard is not a sign that the Ministry has gone soft on bacterial contamination of relevant foods.The new standard will come into effect starting Dec. 21, 2011.

BEIJING, Dec. 30 (Xinhua) -- China will push to properly resolve the case of a Chinese skipper indicted by Japan, the Foreign Ministry said Friday.Spokesman Hong Lei said this is a common fishing case, and the Chinese embassy in Japan has dispatched officials to visit the skipper.China requests that Japan ensure the rights of the Chinese skipper, Hong said, and China is communicating closely with Japan in order to properly resolve the case.The Chinese government has been requiring fishermen to fish legally, Hong said, adding that the competent authorities have done a lot in this area, and he promised to promote the management and education of Chinese fishermen.Japanese prosecutors have indicted the captain of a Chinese fishing boat for illegally operating in Japanese waters, a local official said Friday.The Nagasaki District Public Prosecutors Office has finalized its case against Zhong Jinyin, 39, following his December 20 arrest near islands off southwest Japan, according to the official.The prosecutors have not indicated whether the skipper has admitted to the charge.

BEIJING, Dec. 2 (Xinhua) -- Medical experts and leaders from the world's leading orthopaedic societies on Friday called for the improvement of health insurance programs and medical care for people in developing countries."Health care should reach the unreached," said Professor H.K.T. Raza, president of the Asia Pacific Orthopaedic Association (APOP), at the Sixth International Congress of Chinese Orthopaedic Association (COA), which is running from Thursday to Sunday in Beijing."If we really want to improve people's well-being, we have to make health care available to those who have difficulty accessing it. Although that will probably be a very difficult task, we should try and do it gradually," said Professor K.M. Chan from the Prince of Wales Hospital in Hong Kong.Statistics from the Ministry of Health show that 1.27 billion Chinese, or 95 percent of the country's population, are covered by basic medical insurance programs.However, private medical insurance accounts for less than 2 percent of the country's health care financing, while private insurance in other countries stands at an average of 20 percent."With the increasing demand for quality health care, there will be higher demand for commercial insurance. With more private health funding in the system, we can increase the quality," Prof. Chan said.Government health care expenditures should be directed toward those who can't afford health care at all, while commercial insurance should cover the needs of those who can afford to purchase it, Prof. Chan said."We need to have different approaches combined together to revamp the current health insurance structure in China," he said."If you want to raise the quality of health care, you need to have the responsibility from the government, the individuals and the insurance system," he added.While China may need to promote its commercial health insurance, in India, the situation is different. Though many medical tourists choose India as their destination for affordable care, health insurance is uncommon in the country.While patients typically pay out of their own pockets for routine care, it is estimated that over 300 million Indians out of a population of 1.2 billion still live on less than one U.S. dollar per day.

BEIJING, Oct. 11 (Xinhuanet) -- An experimental drug that can remove amyloid plaques from the brains of Alzheimer's patients is being developed by Swiss Roche Holding AG in a small early-stage study, according to a report published in the Archives of Neurology on Monday.Researchers suspect the build-up of such plaques may be a cause of the memory robbing disease, although that theory has yet to be definitively proved. Gantenerumab, a biotech drug designed to bind to amyloid plaques in the brain and remove them, is being targeted at the early stages of Alzheimer's with the hope it can slow progression of the disease while patients are still able to function.The Phase I study of 16 Alzheimer's patients tested gantenerumab at two doses against a placebo over six months of treatment.The Roche drug led to a dose-dependent reduction of brain amyloid, while amyloid load increased in patients receiving a placebo, the report said.The next step will be to investigate whether removal of brain amyloid translates into clinical benefit for patients at doses of the experimental drug that are well tolerated and safe, the report said.Much larger trials and further study will be needed to fully understand how gantenerumab works and whether it can stave off Alzheimer's, said the report.Roche is approaching the disease far earlier because amyloid accumulates for 15 years before dementi.

SAN FRANCISCO, Oct. 13 (Xinhua) -- The Internet search giant Google on Thursday released its third fiscal quarter earnings report, posting strong numbers that beat analysts' estimates.The Mountain View, California-based company reported revenue of 9.72 billion U.S. dollars for the quarter ending Sept. 30, 2011, an increase of 33 percent on a year-on-year basis.Google reported a profit of 2.73 billion dollars, compared to 2. 17 billion dollars in the same period last year. The earning per share, excluding certain items, is 9.72 dollars, topping the average estimate of 8.74 dollars per share polled by Thomson Reuters."We had a great quarter," said Google co-founder and Chief Executive Officer Larry Page in a statement. "Google+ is now open to everyone and we just passed the 40 million user mark. People are flocking into Google+ at an incredible rate and we are just getting started."Many analysts took the third quarter to examine the company's progress towards expanding its core business beyond advertising which accounted for 96 percent of its revenue last year. In the past quarter, Google made major investments in several key businesses, such as social networking and mobile.In August, Google announced a 12.5-billion-dollar acquisition of Motorola Mobility, a move widely seen to get Motorola's patent portfolio to protect its Android software against a growing number of infringement lawsuits by rival mobile platforms. The deal is expected to close later this year or early next year.Since its late-June launch, the Google+ social network has been receiving a good response, posing to shake up the social networking space dominated by Facebook.In September, Google also officially launched Google Wallet, a mobile payment allowing users to pay by tapping an Android smartphone against a compatible card reader.